We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Franciscan B/C/D180 minsAttend 13-minute presentations across several therapeutic areas.
Imperial Ballroom50 minsSince the passage of the Inflation Reduction Act, companies, investors, and patients have raised concerns about how the legislation will impact innovation in the biotech industry. Will there be a decl ...Moderator
Imperial Ballroom50 minsA Nature biotechnology report cited an analysis of the 25 most active VC firms that shows less than 1% of senior level investment teams have partners from underrepresented racial and ethnic groups. Mc ...
Imperial Ballroom50 minsDr. Julia Owens is an experienced biopharmaceutical CEO and board member with a deep commitment to advancing innovative therapies for patients over a 20+ year professional career. She brings a unique ...
Franciscan B/C/D240 minsAttend 13-minute presentations across several therapeutic areas.
Imperial Ballroom50 minsRelative to other highly prevalent diseases such as cancers or cardiovascular disease, companies seeking therapies for neurodegeneration have struggled with drug delivery and biomarker validation insi ...Speakers
Imperial Ballroom50 minsLast year, Google’s AlphaFold project demonstrated it can model more than 200 million molecular 3-D structures, including nearly all known proteins, by applying computational biology and artificial in ...
Imperial Ballroom50 minsAfter an 80% decline in IPO volume from the 2021 peak and the Federal Reserve’s start of raising interest rates, conditions appear now to be shifting towards stabilizing rates and slowly opening the I ...Speakers